Downloads Popup Form

Please review our privacy policy so you understand how we collect and use your personal data.

Please review our privacy policy so you understand how we collect and use your personal data.

Improving In Vitro Test Methods for Nasal Drug Products

In this article, we look at how in vitro testing is being refined for greater repeatability and to maximise its value as a low-cost tool for product development, including an assessment of the role of automation in improving the sensitivity of in vitro testing.

This article is taken from from ONdrugDelivery November 2021. © 2024 Frederick Furness Publishing.

 

Download PDF
Improving In Vitro Test Methods for Nasal Drug Products

You may also be interested in:

Establishing an Optimal Test Set-up for Delivered Dose Uniformity Testing for Nasal Drug Products

Improving Performance in Inhaled Therapeutics 

Reducing Variability in the Inhaler Testing Environment

Better In Vivo Prediction from OINDP Testing: A Goal Worth Pursuing?

Improving the Utility of In Vitro Test Methods for Intranasal Drug Delivery

OINDPnews Q&A With Copley’s Clair Brooks on In Vitro Testing for LGWP MDI Reformulation

Training & Support

Find out more about the broad range of training opportunities and comprehensive support we offer customers

Training

Training

We offer a range of training courses, presentations and seminars covering a wide range of topics Find out more
Servicing

Servicing

A comprehensive range of both in-house and on-site product servicing options are available Find out more
Support

Support

Our team of experienced technicians and engineers are on hand to help and advise Find out more

Downloads

Access the latest product brochures, whitepapers and other useful content

Find out more